Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Head and Neck Cancer

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 229 articles:
HTML format

Single Articles

    September 2021
  1. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    PubMed     Abstract available

  2. NABHAN F, Dedhia PH, Ringel MD
    Thyroid cancer, recent advances in diagnosis and therapy.
    Int J Cancer. 2021;149:984-992.
    PubMed     Abstract available

    July 2021
  3. NAUTA IH, Heideman DAM, Brink A, van der Steen B, et al
    The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
    Int J Cancer. 2021;149:420-430.
    PubMed     Abstract available

    June 2021
  4. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.

  5. TRUONG T, Lesueur F, Sugier PE, Guibon J, et al
    Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
    Int J Cancer. 2021;148:2935-2946.
    PubMed     Abstract available

    May 2021
  6. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    PubMed     Abstract available

  7. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
    Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
    Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
    PubMed     Abstract available

    April 2021
  8. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
    Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
    PubMed     Abstract available

  9. LIU C, Song K, Hu Q, Hu C, et al
    Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.
    Int J Cancer. 2021;148:1789-1793.

  10. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    PubMed     Abstract available

  11. LING Z, Cheng B, Tao X
    Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
    Int J Cancer. 2021;148:1548-1561.
    PubMed     Abstract available

    March 2021
  12. NARUSAKA T, Ohara T, Noma K, Nishiwaki N, et al
    Nanog is a promising chemo-resistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
    Int J Cancer. 2021 Mar 4. doi: 10.1002/ijc.33544.
    PubMed     Abstract available

  13. MIDDLETON DRS, Mmbaga BT, O'Donovan M, Abedi-Ardekani B, et al
    Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.
    Int J Cancer. 2021;148:1208-1218.
    PubMed     Abstract available

  14. IMAMURA Y, Toihata T, Haraguchi I, Ogata Y, et al
    Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Int J Cancer. 2021;148:1260-1275.
    PubMed     Abstract available

  15. LIU Y, Lai F, Long J, Peng S, et al
    Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases.
    Int J Cancer. 2021;148:1106-1114.
    PubMed     Abstract available

    February 2021
  16. PARAD MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S, et al
    Thyroid cancer and its associated factors: a population based case-control study.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33537.
    PubMed     Abstract available

  17. XIE SH, Ness-Jensen E, Langseth H, Gislefoss RE, et al
    Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
    Int J Cancer. 2021;148:905-913.
    PubMed     Abstract available

    January 2021
  18. TAKADA K, Aizawa Y, Sano D, Okuda R, et al
    Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Int J Cancer. 2021;148:193-202.
    PubMed     Abstract available

    December 2020
  19. VON WITZLEBEN A, Fehn A, Grages A, EziC J, et al
    Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC).
    Int J Cancer. 2020 Dec 17. doi: 10.1002/ijc.33446.
    PubMed     Abstract available

  20. GETZ KR, Bellile E, Zarins KR, Rullman C, et al
    Statin Use and Head and Neck Squamous Cell Carcinoma Outcomes.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33441.
    PubMed     Abstract available

  21. MMBAGA BT, Mwasamwaja A, Mushi G, Mremi A, et al
    Missing and Decayed Teeth, Oral Hygiene and Dental Staining in relation to Esophageal Cancer Risk: ESCCAPE case-control study in Kilimanjaro Tanzania.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33433.
    PubMed     Abstract available

  22. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    PubMed     Abstract available

  23. ANTONSSON A, de Souza M, Wood ZC, Carroll A, et al
    Natural history of oral HPV infection - longitudinal analyses in prospective cohorts from Australia.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33442.
    PubMed     Abstract available

  24. CHEN GH, Liu Z, Ji MF, Pfeiffer RM, et al
    Prospective Assessment of a Nasopharyngeal Carcinoma Risk Score in a Population Undergoing Screening.
    Int J Cancer. 2020 Dec 7. doi: 10.1002/ijc.33424.
    PubMed     Abstract available

  25. YANG CS, Chen XL
    Research on esophageal cancer: with personal perspectives from studies in China and Kenya.
    Int J Cancer. 2020 Dec 3. doi: 10.1002/ijc.33421.
    PubMed     Abstract available

    November 2020
  26. SONG L, Zhang S, Yu S, Ma F, et al
    Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
    Int J Cancer. 2020;147:2879-2890.
    PubMed     Abstract available

  27. CAPPAGLI V, Caldarella A, Manneschi G, Piaggi P, et al
    Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Int J Cancer. 2020;147:2838-2846.
    PubMed     Abstract available

  28. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    PubMed     Abstract available

  29. JUWEID ME, Tulchinsky M, Mismar A, Momani M, et al
    Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
    Int J Cancer. 2020;147:2345-2354.
    PubMed     Abstract available

    October 2020
    Esophageal sponge sampling: a promising approach for early detection of esophageal cancer in Africa's high-incidence region.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33372.

  31. BASILI T, Dopeso H, Kim SH, Ferrando L, et al
    Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Int J Cancer. 2020;147:2253-2264.
    PubMed     Abstract available

  32. YUAN S, Kar S, Vithayathil M, Carter P, et al
    Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
    Int J Cancer. 2020;147:1895-1903.
    PubMed     Abstract available

    September 2020
  33. ZHANG J, Luo X, Huang Q, Huang Y, et al
    Clinicopathological and Prognostic Features of Nasopharyngeal Carcinoma in Children and Adolescents: A Retrospective Study of 196 Cases in South China.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33293.
    PubMed     Abstract available

  34. BUCKLE GC, Mahapatra R, Mwachiro M, Akoko L, et al
    Optimal management of esophageal cancer in Africa: A systemic review of treatment strategies.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33299.
    PubMed     Abstract available

  35. PLATH M, Gass J, Hlevnjak M, Li Q, et al
    Unraveling most abundant mutational signatures in head and neck cancer.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33297.
    PubMed     Abstract available

  36. SIRRI E, Kieschke J, Vohmann C, Katalinic A, et al
    Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
    Int J Cancer. 2020;147:1548-1558.
    PubMed     Abstract available

  37. MOHEBBI E, Hadji M, Rashidian H, Rezaianzadeh A, et al
    Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma.
    Int J Cancer. 2020 Sep 7. doi: 10.1002/ijc.33289.
    PubMed     Abstract available

  38. TANAKA H, Takemoto N, Horie M, Takai E, et al
    Circulating Tumor HPV DNA Complements PET-CT in Guiding Management after Radiotherapy in HPV-Related Squamous Cell Carcinoma of the Head and Neck.
    Int J Cancer. 2020 Sep 7. doi: 10.1002/ijc.33287.
    PubMed     Abstract available

    August 2020
  39. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
    Global trends in oral and pharyngeal cancer incidence and mortality.
    Int J Cancer. 2020;147:1040-1049.
    PubMed     Abstract available

  40. WALPOLE E, Dunn N, Youl P, Harden H, et al
    Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Int J Cancer. 2020;147:856-865.
    PubMed     Abstract available

  41. DALMARTELLO M, Decarli A, Ferraroni M, Bravi F, et al
    Dietary patterns and oral and pharyngeal cancer using latent class analysis.
    Int J Cancer. 2020;147:719-727.
    PubMed     Abstract available

    July 2020
  42. CHEN W, Li H, Ren J, Zheng R, et al
    Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Int J Cancer. 2020 Jul 14. doi: 10.1002/ijc.33208.
    PubMed     Abstract available

  43. HOLMBERG D, Ness-Jensen E, Mattsson F, Lagergren J, et al
    Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
    Int J Cancer. 2020;147:93-99.
    PubMed     Abstract available

    June 2020
  44. HU Y, Zhang X, Wang O, Bi Y, et al
    The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
    Int J Cancer. 2020 Jun 23. doi: 10.1002/ijc.33166.
    PubMed     Abstract available

  45. SINGHAVI HR, Chakrabarti S, Singh A, Mair M, et al
    Comparison of the seventh and eighth editions American Joint Committee Cancer classification system in oral cavity squamous cell cancers.
    Int J Cancer. 2020;146:3379-3384.
    PubMed     Abstract available

  46. FACOMPRE ND, Rajagopalan P, Sahu V, Pearson AT, et al
    Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Int J Cancer. 2020 Jun 1. doi: 10.1002/ijc.33125.
    PubMed     Abstract available

  47. DEMOURY C, De Schutter H, Faes C, Carbonnelle S, et al
    Thyroid cancer incidence near nuclear sites in Belgium: An ecological study at small geographical level.
    Int J Cancer. 2020;146:3034-3043.
    PubMed     Abstract available

  48. VAN BOXTEL W, Verhaegh GW, van Engen-van Grunsven IA, van Strijp D, et al
    Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
    Int J Cancer. 2020;146:3196-3206.
    PubMed     Abstract available

    May 2020
  49. MESSERSCHMIDT C, Obermayer B, Klinghammer K, Ochsenreither S, et al
    Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Int J Cancer. 2020 May 29. doi: 10.1002/ijc.33123.
    PubMed     Abstract available

  50. TAY JK, Siow CH, Goh HL, Lim CM, et al
    A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Int J Cancer. 2020;146:2923-2931.
    PubMed     Abstract available

  51. HOLLECZEK B, Schottker B, Brenner H
    Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study.
    Int J Cancer. 2020;146:2773-2783.
    PubMed     Abstract available

    April 2020
  52. REN J, Xu W, Su J, Ren X, et al
    Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
    Int J Cancer. 2020;146:2166-2174.
    PubMed     Abstract available

  53. SIMON J, Schroeder L, Ingarfield K, Diehl S, et al
    Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Int J Cancer. 2020 Apr 12. doi: 10.1002/ijc.33006.
    PubMed     Abstract available

  54. ZAMORA-ROS R, Cayssials V, Franceschi S, Kyro C, et al
    Polyphenol intake and differentiated thyroid cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2020;146:1841-1850.
    PubMed     Abstract available

    March 2020
  55. TIAN W, Zhu F, Cai J, Li L, et al
    Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma (NPC) patients in Hunan province, southern China.
    Int J Cancer. 2020 Mar 24. doi: 10.1002/ijc.32992.
    PubMed     Abstract available

  56. ESSERS PBM, van der Heijden M, Vossen D, de Roest RH, et al
    Ovarian cancer derived copy number alterations signatures are prognostic in chemoradiotherapy treated head and neck squamous cell carcinoma.
    Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32962.
    PubMed     Abstract available

    February 2020
  57. ZHOU C, Diao P, Wu Y, Wei Z, et al
    Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
    Int J Cancer. 2020;146:1152-1163.
    PubMed     Abstract available

  58. ZSCHAECK S, Li Y, Butof R, Lili C, et al
    Combined tumor plus non-tumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32897.
    PubMed     Abstract available

    January 2020
  59. NAKAGAWA T, Matsusaka K, Misawa K, Ota S, et al
    Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
    Int J Cancer. 2020 Jan 30. doi: 10.1002/ijc.32890.
    PubMed     Abstract available

  60. MASTERSON L, Howard J, Gonzalez-Cruz J, Jackson C, et al
    Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?
    Int J Cancer. 2020 Jan 17. doi: 10.1002/ijc.32869.
    PubMed     Abstract available

  61. MONTERO-CONDE C, Grana-Castro O, Martin-Serrano G, Martinez-Montes AM, et al
    Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
    Int J Cancer. 2020;146:521-530.
    PubMed     Abstract available

    December 2019
  62. SU TH, Tseng TC, Liu CJ, Chou SW, et al
    Antiviral Therapy against Chronic Hepatitis C is Associated with a Reduced Risk of Oral Cancer.
    Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32840.
    PubMed     Abstract available

  63. PALACIOS-GARCIA J, Sanz-Flores M, Asensio A, Alvarado R, et al
    G-protein coupled receptor kinase 2 safeguards epithelial phenotype in Head and Neck Squamous Cell Carcinomas.
    Int J Cancer. 2019 Dec 18. doi: 10.1002/ijc.32838.
    PubMed     Abstract available

  64. WILKAT M, Bast H, Drees R, Dunser J, et al
    Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells.
    Int J Cancer. 2019 Dec 17. doi: 10.1002/ijc.32835.
    PubMed     Abstract available

  65. BORNSCHEIN J, Wernisch L, Secrier M, Miremadi A, et al
    Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
    Int J Cancer. 2019;145:3389-3401.
    PubMed     Abstract available

  66. CHANG CP, Siwakoti B, Sapkota A, Gautam DK, et al
    Tobacco smoking, chewing habits, alcohol drinking and the risk of head and neck cancer in Nepal.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32823.
    PubMed     Abstract available

    November 2019
  67. VEYER D, Wack M, Mandavit M, Garrigou S, et al
    HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.

  68. LEHTINEN M, Apter D, Eriksson T, Harjula K, et al
    Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females - results from a community-randomized trial.
    Int J Cancer. 2019 Nov 17. doi: 10.1002/ijc.32791.
    PubMed     Abstract available

  69. ETEMADI A, Islami F, Abnet CC, Malekzadeh R, et al
    Author's reply to comment on "A prospective study of tea drinking temperature..." by Islami et al.
    Int J Cancer. 2019;145:2888-2889.

  70. STEINS A, Ebbing EA, Creemers A, van der Zalm AP, et al
    Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
    Int J Cancer. 2019;145:2792-2803.
    PubMed     Abstract available

  71. SEPULVEDA JL, Komissarova EV, Kongkarnka S, Friedman RA, et al
    High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
    Int J Cancer. 2019;145:2754-2766.
    PubMed     Abstract available

  72. RYAN N, Anderson K, Volpedo G, Hamza O, et al
    STAT1 inhibits T cell exhaustion and myeloid derived suppressor cell accumulation to promote anti-tumor immune responses in head and neck squamous cell carcinoma.
    Int J Cancer. 2019 Nov 10. doi: 10.1002/ijc.32781.
    PubMed     Abstract available

  73. WU J, Dai W, Wu L, Li W, et al
    Decoding genetic and epigenetic information embedded in cell free DNA with adapted SALP-seq.
    Int J Cancer. 2019;145:2395-2406.
    PubMed     Abstract available

    October 2019
  74. AVERSA J, Song M, Shimazu T, Inoue M, et al
    Prediagnostic Circulating Inflammation Biomarkers and Esophageal Squamous Cell Carcinoma: A Case-Cohort Study in Japan.
    Int J Cancer. 2019 Oct 31. doi: 10.1002/ijc.32763.
    PubMed     Abstract available

  75. RUICCI KM, Meens J, Sun RX, Rizzo G, et al
    A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kalpha inhibition in controlling tumor growth.
    Int J Cancer. 2019;145:2100-2106.
    PubMed     Abstract available

  76. BECKHAM TH, Barney C, Healy E, Wolfe AR, et al
    Platinum-Based Regimens Versus Cetuximab in Definitive Chemoradiation for Human Papillomavirus-Unrelated Head and Neck Cancer.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32736.
    PubMed     Abstract available

  77. LEONG MML, Cheung AKL, Kwok TCT, Lung ML, et al
    Functional Characterization of a Candidate Tumor Suppressor Gene, Mirror Image Polydactyly 1, in Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32732.
    PubMed     Abstract available

  78. MADATHIL S, Rousseau MC, Joseph L, Coutlee F, et al
    Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32708.
    PubMed     Abstract available

  79. BETTAMPADI D, Villa LL, Lazcano Ponce E, Salmeron J, et al
    Oral Human Papillomavirus Prevalence and Type Distribution by Country (Brazil, Mexico and the United States) and Age among HPV Infection in Men (HIM) Study Participants.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32713.
    PubMed     Abstract available

    September 2019
  80. KANO M, Kondo S, Wakisaka N, Wakae K, et al
    Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
    Int J Cancer. 2019;145:1547-1557.
    PubMed     Abstract available

  81. KIM EJ, Kim JS, Lee S, Lee H, et al
    QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
    Int J Cancer. 2019;145:1585-1595.
    PubMed     Abstract available

  82. REN J, Yang W, Su J, Ren X, et al
    Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region.
    Int J Cancer. 2019;145:1465-1474.
    PubMed     Abstract available

  83. RANJAN D
    Comment on "A Prospective Study of Tea Drinking Temperature.." by Islami et al.
    Int J Cancer. 2019;145:1445.

  84. ISLAMI F, Kamangar F, Malekzadeh R
    Reply to Comment on "A prospective study of tea drinking temperature.. " by Islami et al.
    Int J Cancer. 2019;145:1446-1447.

  85. YANG JG, Wang WM, Xia HF, Yu ZL, et al
    Lymphotoxin-alpha promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
    Int J Cancer. 2019;145:1358-1370.
    PubMed     Abstract available

    August 2019
  86. TAN LP, Tan GW, Sivanesan VM, Goh SL, et al
    Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32656.
    PubMed     Abstract available

  87. GANGKOFNER DS, Holzinger D, Schroeder L, Eichmuller SB, et al
    Patterns of antibody responses to non-viral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Int J Cancer. 2019 Aug 12. doi: 10.1002/ijc.32623.
    PubMed     Abstract available

  88. KO JM, Ning L, Zhao XK, Chai AW, et al
    BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
    Int J Cancer. 2019 Aug 9. doi: 10.1002/ijc.32619.
    PubMed     Abstract available

  89. GANLY I, Yang L, Giese RA, Hao Y, et al
    Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.
    Int J Cancer. 2019;145:775-784.
    PubMed     Abstract available

    July 2019
  90. ANUSIC T, Gianicolo EAL
    Comment on "A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma" by Islami et al.
    Int J Cancer. 2019 Jul 31. doi: 10.1002/ijc.32601.

  91. PRITCHETT NR, Maziarz M, Shu XO, Kamangar F, et al
    Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
    Int J Cancer. 2019 Jul 27. doi: 10.1002/ijc.32597.
    PubMed     Abstract available

  92. DIJKSTERHUIS WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, et al
    Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real-world evidence study.
    Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32580.
    PubMed     Abstract available

  93. GIULIANO AR, Nedjai B, Lorincz AT, Schell MJ, et al
    Methylation Of Hpv 16 And Epb41l3 In Oral Gargles: Associations With Oropharyngeal Cancer Detection And Tumor Characteristics.
    Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32570.
    PubMed     Abstract available

  94. DOK R, Bamps M, Glorieux M, Zhao P, et al
    Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32558.
    PubMed     Abstract available

  95. DOVEY DE LA COUR C, Dehlendorff C, Aalborg GL, von Buchwald C, et al
    Use of nonaspirin non-steroidal anti-inflammatory drugs and risk of head and neck cancer: a nationwide case-control study.
    Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32544.
    PubMed     Abstract available

    June 2019
  96. TRONKO M, Brenner AV, Bogdanova T, Shpak V, et al
    Reply to letter: Thyroid neoplasia after Chernobyl: A comment.
    Int J Cancer. 2019;144:2898.

    Thyroid neoplasia after Chernobyl: A comment.
    Int J Cancer. 2019;144:2897.

  98. MIDDLETON DR, Menya D, Kigen N, Oduor M, et al
    Hot beverages and oesophageal cancer risk in western Kenya: Findings from the ESCCAPE case-control study.
    Int J Cancer. 2019;144:2669-2676.
    PubMed     Abstract available

  99. WANG SH, Liou GG, Liu SH, Chang JS, et al
    Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin alpha3-dependent uptake by lymphatic endothelial cells.
    Int J Cancer. 2019;144:2795-2810.
    PubMed     Abstract available

  100. SZYFTER K, Napierala M, Florek E, Braakhuis BJM, et al
    Molecular and health effects in the upper respiratory tract associated with tobacco smoking other than cigarettes.
    Int J Cancer. 2019;144:2635-2643.
    PubMed     Abstract available

    May 2019
  101. SCHMITT K, Molfenter B, Koerich Laureano N, Tawk B, et al
    Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
    Int J Cancer. 2019 May 28. doi: 10.1002/ijc.32481.
    PubMed     Abstract available

  102. DOGAN S, Xu B, Middha S, Vanderbilt CM, et al
    Identification of Prognostic Molecular Biomarkers in 157 HPV-positive and HPV-negative Squamous Cell Carcinomas of the Oropharynx.
    Int J Cancer. 2019 May 16. doi: 10.1002/ijc.32412.
    PubMed     Abstract available

  103. RAMAYANTI O, Verkuijlen SAWM, Novianti P, Scheepbouwer C, et al
    Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Int J Cancer. 2019;144:2555-2566.
    PubMed     Abstract available

  104. SANIKINI H, Muller DC, Sophiea M, Rinaldi S, et al
    Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32386.
    PubMed     Abstract available

  105. YOU R, Liu YP, Lin M, Huang PY, et al
    Relationship of Circulating Tumor Cells and Epstein-Barr Virus DNA to Progression-Free Survival and Overall Survival in Metastatic Nasopharyngeal Carcinoma Patients.
    Int J Cancer. 2019 May 1. doi: 10.1002/ijc.32380.
    PubMed     Abstract available

  106. GUNDA V, Gigliotti B, Ashry T, Ndishabandi D, et al
    Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer.
    Int J Cancer. 2019;144:2266-2278.
    PubMed     Abstract available

  107. ZHANG K, Dai H, Liang W, Zhang L, et al
    Fermented dairy foods intake and risk of cancer.
    Int J Cancer. 2019;144:2099-2108.
    PubMed     Abstract available

  108. LORTET-TIEULENT J, Franceschi S, Dal Maso L, Vaccarella S, et al
    Thyroid cancer "epidemic" also occurs in low- and middle-income countries.
    Int J Cancer. 2019;144:2082-2087.
    PubMed     Abstract available

    April 2019
  109. HAAG GM, Czink E, Ahadova A, Schmidt T, et al
    Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Int J Cancer. 2019;144:1697-1703.
    PubMed     Abstract available

  110. NOH Y, Jeon SM, Shin S
    Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy.
    Int J Cancer. 2019;144:1530-1539.
    PubMed     Abstract available

  111. LEE VH, Kwong DL, Leung TW, Choi CW, et al
    The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
    Int J Cancer. 2019;144:1713-1722.
    PubMed     Abstract available

    March 2019
  112. BISWAS NK, Das C, Das S, Maitra A, et al
    Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32305.
    PubMed     Abstract available

  113. LIU CC, Chou KT, Hsu JW, Lin JH, et al
    High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32301.
    PubMed     Abstract available

  114. ISLAMI F, Poustchi H, Pourshams A, Khoshnia M, et al
    A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32220.
    PubMed     Abstract available

  115. LIU X, Song M, Wang P, Zhao R, et al
    Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Int J Cancer. 2019 Mar 18. doi: 10.1002/ijc.32285.
    PubMed     Abstract available

  116. YE F, Gao H, Xiao L, Ding H, et al
    Reply to Cirello et al. "Absence of the MAP2K5 germline variants c.G961A and c. T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families." International Journal of Cancer 2019; in press.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32243.

  117. CIRELLO V, Colombo C, Persani L, Fugazzola L, et al
    Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32244.

    January 2019
  118. TAN GW, Sivanesan VM, Abdul Rahman FI, Hassan F, et al
    A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32173.
    PubMed     Abstract available

  119. NOVOPLANSKY O, Fury M, Prasad M, Yegodayev K, et al
    MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32170.
    PubMed     Abstract available

  120. KAWAKITA D, Lee YA, Gren LH, Buys SS, et al
    Fiber Intake and the Risk of Head and Neck Cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32162.
    PubMed     Abstract available

  121. WU C, Nilsson K, Zheng Y, Ekenstierna C, et al
    Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs.
    Int J Cancer. 2019;144:297-310.
    PubMed     Abstract available

  122. AL-SAHAF S, Hunter KD, Bolt R, Ottewell PD, et al
    The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
    Int J Cancer. 2019;144:334-344.
    PubMed     Abstract available

  123. LI WF, Chen NY, Zhang N, Hu GQ, et al
    Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
    Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32099.
    PubMed     Abstract available

    December 2018
  124. MENYA D, Maina SK, Kibosia C, Kigen N, et al
    Dental fluorosis and oral health in the African Esophageal Cancer Corridor: Findings from the Kenya ESCCAPE case-control study and a pan-African perspective.
    Int J Cancer. 2018 Dec 23. doi: 10.1002/ijc.32086.
    PubMed     Abstract available

  125. GRABER JM, Harris G, Black K, Lucchini RG, et al
    Excess HPV-related head and neck cancer in the World Trade Center Health Program General Responder cohort.
    Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32070.
    PubMed     Abstract available

  126. HUI KF, Chan TF, Yang W, Shen JJ, et al
    High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32049.
    PubMed     Abstract available

    November 2018
  127. MATOBA T, Imai M, Ohkura N, Kawakita D, et al
    Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32024.
    PubMed     Abstract available

  128. ZHANG Y, Tang LL, Li YQ, Liu X, et al
    Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32021.
    PubMed     Abstract available

  129. FENG J, Zhao F, Sun J, Lin B, et al
    Alterations in the Gut Microbiota and Metabolite Profiles of Thyroid Carcinoma Patients.
    Int J Cancer. 2018 Nov 22. doi: 10.1002/ijc.32007.
    PubMed     Abstract available

  130. KINOUCHI M, Izumi S, Nakashiro KI, Haruyama Y, et al
    Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?
    Int J Cancer. 2018;143:2551-2560.
    PubMed     Abstract available

  131. REN S, Gaykalova D, Wang J, Guo T, et al
    Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2018;143:2425-2436.
    PubMed     Abstract available

  132. SAHNANE N, Ottini G, Turri-Zanoni M, Furlan D, et al
    Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal inverted papilloma to squamous cell carcinoma.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31971.
    PubMed     Abstract available

  133. KITAHARA CM, Preston DL, Neta G, Little MP, et al
    Occupational radiation exposure and thyroid cancer incidence in a cohort of U.S. radiologic technologists, 1983-2013.
    Int J Cancer. 2018;143:2145-2149.
    PubMed     Abstract available

    October 2018
  134. KASHIMA H, Noma K, Ohara T, Kato T, et al
    Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31953.
    PubMed     Abstract available

  135. HUEBBERS CU, Verhees F, Poluschkin L, Olthof NC, et al
    Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31954.

  136. CUI M, Hu Y, Bi Y, Wang W, et al
    Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31948.
    PubMed     Abstract available

  137. HESARI A, Azizian M, Sheikh A, Nesaei A, et al
    Chemopreventive and therapeutic potential of curcumin in esophageal cancer: current and future status.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31947.
    PubMed     Abstract available

  138. SONG E, Oh HS, Jeon MJ, Chung KW, et al
    The value of preoperative anti-thyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 25. doi: 10.1002/ijc.31944.
    PubMed     Abstract available

  139. JENDRZEJEWSKI J, Liyanarachchi S, Eiterman A, Thomas A, et al
    Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 23. doi: 10.1002/ijc.31933.
    PubMed     Abstract available

  140. HUANG FQ, Li J, Jiang L, Wang FX, et al
    Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 14. doi: 10.1002/ijc.31925.
    PubMed     Abstract available

    September 2018
  141. HUFBAUER M, Maltseva M, Meinrath J, Lechner A, et al
    HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Int J Cancer. 2018;143:1426-1439.
    PubMed     Abstract available

  142. TAO Y, Sturgis EM, Huang Z, Sun Y, et al
    A TGF-beta1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.
    Int J Cancer. 2018;143:1327-1334.
    PubMed     Abstract available

  143. DUDDING T, Johansson M, Thomas SJ, Brennan P, et al
    Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization.
    Int J Cancer. 2018;143:1029-1036.
    PubMed     Abstract available

    August 2018
  144. KAUPPILA JH, Wahlin K, Lagergren P, Lagergren J, et al
    Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31840.
    PubMed     Abstract available

  145. YE F, Gao H, Xiao L, Zuo Z, et al
    Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31825.
    PubMed     Abstract available

  146. MENYA D, Kigen N, Oduor M, Maina SK, et al
    Traditional and commercial alcohols and esophageal cancer risk in Kenya.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31804.
    PubMed     Abstract available

  147. BAO C, Pedersen NL, Yang R, Marseglia A, et al
    Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2018;143:793-800.
    PubMed     Abstract available

  148. ZHANG Y, Yuan Y, Wu H, Xie Z, et al
    Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
    Int J Cancer. 2018;143:980-991.
    PubMed     Abstract available

  149. MC MENAMIN UC, Kunzmann AT, Cook MB, Johnston BT, et al
    Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Int J Cancer. 2018;143:831-841.
    PubMed     Abstract available

  150. BOON E, Bel M, van Boxtel W, van der Graaf WTA, et al
    A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Int J Cancer. 2018;143:758-766.
    PubMed     Abstract available

  151. OCK S, Ahn J, Lee SH, Kim HM, et al
    Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31779.
    PubMed     Abstract available

    July 2018
  152. ROY R, Kandimalla R, Sonohara F, Koike M, et al
    A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31755.
    PubMed     Abstract available

  153. CHEN X, Wang L, Li P, Song M, et al
    Dual TGF-beta and PD-1 blockade synergistically enhances MAGE-A3-specific CD8(+) T cell response in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31730.
    PubMed     Abstract available

  154. JIANG C, Chen J, Xie S, Zhang L, et al
    Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31642.
    PubMed     Abstract available

  155. PENG SY, Tu HF, Yang CC, Wu CH, et al
    miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31638.
    PubMed     Abstract available

  156. ABRAHAO R, Anantharaman D, Gaborieau V, Abedi-Ardekani B, et al
    The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
    Int J Cancer. 2018;143:32-44.
    PubMed     Abstract available

  157. SPENCE AD, Busby J, Murchie P, Kunzmann AT, et al
    Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.
    Int J Cancer. 2018;143:22-31.
    PubMed     Abstract available

    June 2018
  158. KO JM, Tsang KH, Dai W, Choi SSA, et al
    Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31617.
    PubMed     Abstract available

    May 2018
  159. BU R, Siraj AK, Divya SP, Kong Y, et al
    Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
    Int J Cancer. 2018;142:2028-2039.
    PubMed     Abstract available

    April 2018
  160. YU C, Guo Y, Bian Z, Yang L, et al
    Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31566.
    PubMed     Abstract available

  161. MAZUL AL, Shivappa N, Hebert JR, Steck SE, et al
    Proinflammatory diet is associated with increased risk of squamous cell head and neck cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31555.
    PubMed     Abstract available

  162. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31534.
    PubMed     Abstract available

  163. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 12. doi: 10.1002/ijc.31426.
    PubMed     Abstract available

  164. BEYNON RA, Lang S, Schimansky S, Penfold CM, et al
    Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from Head and Neck 5000, a prospective observational cohort of people with head and neck cancer.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31416.

  165. SCHROEDER L, Wichmann G, Willner M, Michel A, et al
    Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
    Int J Cancer. 2018;142:1361-1368.
    PubMed     Abstract available

    March 2018
  166. ARTHUR AE, Goss AM, Demark-Wahnefried W, Mondul AM, et al
    Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: Results from a prospective cohort study.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31413.
    PubMed     Abstract available

  167. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    PubMed     Abstract available

  168. XIE SL, Fan S, Zhang SY, Chen WX, et al
    SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/beta-catenin pathway.
    Int J Cancer. 2018;142:1252-1265.
    PubMed     Abstract available

    February 2018
  169. CHUNG YL, Wu ML
    Spatiotemporal homogeneity and distinctness of the T-cell receptor beta-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas.
    Int J Cancer. 2018 Feb 22. doi: 10.1002/ijc.31336.
    PubMed     Abstract available

  170. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
    Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
    PubMed     Abstract available

  171. CHAN KKW, Saluja R, Delos Santos K, Lien K, et al
    Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31312.
    PubMed     Abstract available

  172. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    PubMed     Abstract available

    January 2018
  173. WANG YQ, Chen YP, Zhang Y, Jiang W, et al
    Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Int J Cancer. 2018 Jan 27. doi: 10.1002/ijc.31279.
    PubMed     Abstract available

  174. LEEMAN JE, McBride SM, Spielsinger D, Sherman EJ, et al
    Head and Neck Cancers Associated with Exposure to the September 11, 2001 World Trade Center Terrorist Attacks.
    Int J Cancer. 2018 Jan 25. doi: 10.1002/ijc.31277.
    PubMed     Abstract available

  175. MERMOD M, Hiou-Feige A, Bovay E, Roh V, et al
    Mouse model of post-surgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
    Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31240.
    PubMed     Abstract available

    December 2017
  176. SIEW SS, Martinsen JI, Kjaerheim K, Sparen P, et al
    Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma.
    Int J Cancer. 2017;141:2430-2436.
    PubMed     Abstract available

  177. STANGL S, Tontcheva N, Sievert W, Shevtsov M, et al
    Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31213.
    PubMed     Abstract available

  178. ANDERSON C, Engel SM, Weaver MA, Zevallos JP, et al
    Birth rates after radioactive iodine treatment for differentiated thyroid cancer.
    Int J Cancer. 2017;141:2291-2295.
    PubMed     Abstract available

  179. BERANIA I, Cardin GB, Clement I, Guertin L, et al
    Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
    Int J Cancer. 2017;141:2318-2328.
    PubMed     Abstract available

    November 2017
  180. DOSSUS L, Franceschi S, Biessy C, Navionis AS, et al
    Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31172.
    PubMed     Abstract available

  181. YUNHONG T, Jie L, Yunming T, Guoqian Z, et al
    Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Int J Cancer. 2017 Nov 16. doi: 10.1002/ijc.31157.
    PubMed     Abstract available

  182. RAJENDRA S, Yang T, Xuan W, Sharma P, et al
    Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Int J Cancer. 2017;141:2037-2049.
    PubMed     Abstract available

  183. HU J, Li H, Luo X, Li Y, et al
    The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.
    Int J Cancer. 2017;141:1722-1729.
    PubMed     Abstract available

    October 2017
  184. MAO L, Zhao ZL, Yu GT, Wu L, et al
    gamma-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31115.
    PubMed     Abstract available

  185. HOFFMANN M, Pasch S, Schamberger T, Maneck M, et al
    Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31108.
    PubMed     Abstract available

  186. TRONKO M, Brenner AV, Bogdanova T, Shpak V, et al
    Thyroid neoplasia risk is increased nearly 30 years after the Chernobyl accident.
    Int J Cancer. 2017;141:1585-1588.
    PubMed     Abstract available

  187. ZHU L, Sturgis EM, Zhang H, Lu Z, et al
    Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Int J Cancer. 2017;141:1355-1364.
    PubMed     Abstract available

  188. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Abstract available

    September 2017
  189. KLINGHAMMER K, Keller J, George J, Hoffmann J, et al
    A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31045.
    PubMed     Abstract available

  190. LIU J, Lv L, Gong J, Tan Y, et al
    Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38alpha- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31040.
    PubMed     Abstract available

    August 2017
  191. FOUNTZILAS G, Psyrri A, Giannoulatou E, Tikas I, et al
    Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
    Int J Cancer. 2017 Aug 31. doi: 10.1002/ijc.31023.
    PubMed     Abstract available

  192. TWAROCK S, Reichert C, Peters U, Gorski DJ, et al
    Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.
    Int J Cancer. 2017;141:791-804.
    PubMed     Abstract available

  193. SHIVAPPA N, Hebert JR, Rosato V, Garavello W, et al
    Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy.
    Int J Cancer. 2017;141:471-479.
    PubMed     Abstract available

    July 2017
  194. WANG YK, Chuang YS, Wu TS, Lee KW, et al
    Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors and outcomes.
    Int J Cancer. 2017 Jul 30. doi: 10.1002/ijc.30911.
    PubMed     Abstract available

  195. KAWAKITA D, Amy Lee YC, Turati F, Parpinel M, et al
    Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30886.
    PubMed     Abstract available

  196. ZAMORA-ROS R, Beraud V, Franceschi S, Cayssials V, et al
    Consumption of fruits, vegetables, and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Int J Cancer. 2017 Jul 8. doi: 10.1002/ijc.30880.
    PubMed     Abstract available

    June 2017
  197. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
    Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2017;140:2748-2757.
    PubMed     Abstract available

  198. BOSCOLO-RIZZO P, Dietz A
    The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30837.

  199. YOU R, Sun R, Hua YJ, Li CF, et al
    Cetuximab or Nimotuzumab plus Intensity-modulated Radiotherapy Versus Cisplatin plus Intensity-modulated Radiotherapy for Stage II-IVb Nasopharyngeal Carcinoma.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30819.
    PubMed     Abstract available

  200. MILLRUD CR, Kagedal A, Kumlien Georen S, Winqvist O, et al
    NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC.
    Int J Cancer. 2017;140:2557-2567.
    PubMed     Abstract available

    May 2017
  201. MIRANTI EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, et al
    Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30809.
    PubMed     Abstract available

  202. KLINGHAMMER K, Otto R, Raguse JD, Albers AE, et al
    Basal subtype is predictive for response to cetuximab treatment in patient derived xenografts of squamous cell head and neck cancer.
    Int J Cancer. 2017 May 30. doi: 10.1002/ijc.30808.
    PubMed     Abstract available

  203. CARIOLI G, Negri E, Kawakita D, Garavello W, et al
    Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.
    Int J Cancer. 2017;140:2256-2264.
    PubMed     Abstract available

  204. BALERMPAS P, Rodel F, Krause M, Linge A, et al
    The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2017 May 8. doi: 10.1002/ijc.30770.
    PubMed     Abstract available

  205. MEYERS TJ, Chang SC, Chang PY, Morgenstern H, et al
    Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.
    Int J Cancer. 2017;140:2040-2050.
    PubMed     Abstract available

  206. SPROLL C, Freund AK, Hassel A, Holbling M, et al
    Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
    Int J Cancer. 2017;140:2112-2124.
    PubMed     Abstract available

    April 2017
  207. RENKONEN S, Lee M, Makitie A, Lindstrom LS, et al
    Site-specific familial risk and survival of familial and sporadic head and neck cancer.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30751.
    PubMed     Abstract available

  208. LU Z, Zhang C, Sheng J, Shen J, et al
    T cell receptor beta-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.
    Int J Cancer. 2017 Apr 21. doi: 10.1002/ijc.30743.
    PubMed     Abstract available

  209. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Abstract available

  210. FRANK C, Sundquist J, Yu H, Hemminki A, et al
    Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Int J Cancer. 2017;140:1510-1516.
    PubMed     Abstract available

  211. LEVINGSTON CA, Young MR
    Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
    Int J Cancer. 2017;140:1609-1619.
    PubMed     Abstract available

  212. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Abstract available

    March 2017
  213. GHEIT T, Anantharaman D, Holzinger D, Alemany L, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Int J Cancer. 2017 Mar 29. doi: 10.1002/ijc.30712.
    PubMed     Abstract available

  214. CHEOL PARK G, Roh JL, Cho KJ, Seung Kim J, et al
    18 F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.
    Int J Cancer. 2017;140:1405-1412.
    PubMed     Abstract available

  215. PRIGGE ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M, et al
    Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2017;140:1186-1198.
    PubMed     Abstract available

  216. SCHNELLE C, Whiteman DC, Porceddu SV, Panizza BJ, et al
    Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison.
    Int J Cancer. 2017;140:1027-1034.
    PubMed     Abstract available

    February 2017
  217. LIEDERBACH E, Kyrillos A, Wang CH, Liu JC, et al
    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Int J Cancer. 2017;140:504-512.
    PubMed     Abstract available

    January 2017
  218. FALCONER H, Yin L, Bellocco R, Altman D, et al
    Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden.
    Int J Cancer. 2017 Jan 19. doi: 10.1002/ijc.30606.
    PubMed     Abstract available

  219. MCCORMACK VA, Menya D, Munishi MO, Dzamalala C, et al
    Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.
    Int J Cancer. 2017;140:259-271.
    PubMed     Abstract available

  220. KANEMARU A, Yamamoto K, Kawaguchi M, Fukushima T, et al
    Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
    Int J Cancer. 2017;140:130-141.
    PubMed     Abstract available

    December 2016
  221. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Abstract available

  222. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Abstract available

    September 2016
  223. OGHUMU S, Knobloch TJ, Terrazas C, Varikuti S, et al
    Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
    Int J Cancer. 2016;139:1379-90.
    PubMed     Abstract available

    August 2016
  224. GARNAES E, Frederiksen K, Kiss K, Andersen L, et al
    Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30389.
    PubMed     Abstract available

  225. VAN DIJK BA, Brands MT, Geurts SM, Merkx MA, et al
    Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands.
    Int J Cancer. 2016;139:574-83.
    PubMed     Abstract available

    July 2016
  226. GUO T, Gaykalova DA, Considine M, Wheelan S, et al
    Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;139:373-82.
    PubMed     Abstract available

  227. AL-HEBSHI NN, Li S, Nasher AT, El-Setouhy M, et al
    Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Int J Cancer. 2016;139:363-72.
    PubMed     Abstract available

    June 2016
  228. BODELON C, Untereiner ME, Machiela MJ, Vinokurova S, et al
    Genomic characterization of viral integration sites in HPV-related cancers.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30243.
    PubMed     Abstract available

    February 2016
  229. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.